Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The closing price of Qiagen NV (NYSE: QGEN) was $46.7 for the day, down -0.47% from the previous closing price of $46.92. In other words, the price has decreased by -$0.47 from its previous closing price. On the day, 1.93 million shares were traded. QGEN stock price reached its highest trading level at $46.88 during the session, while it also had its lowest trading level at $46.44.
Ratios:
Our analysis of QGEN’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.60 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 20.29. For the most recent quarter (mrq), Quick Ratio is recorded 1.35 and its Current Ratio is at 1.61. In the meantime, Its Debt-to-Equity ratio is 0.41 whereas as Long-Term Debt/Eq ratio is at 0.25.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on June 24, 2025, initiated with a Overweight rating and assigned the stock a target price of $55.
Robert W. Baird Downgraded its Outperform to Neutral on February 19, 2025, whereas the target price for the stock was revised from $52 to $42.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 15 ’25 when Thierry Bernard bought 25,000 shares for $48.80 per share.
ROLAND SACKERS bought 31,423 shares of QGEN for $1,546,257 on Aug 15 ’25. On Aug 14 ’25, another insider, ROLAND SACKERS, who serves as the Officer of the company, bought 18,577 shares for $49.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, QGEN now has a Market Capitalization of 10126147584 and an Enterprise Value of 10655587328. As of this moment, Qiagen’s Price-to-Earnings (P/E) ratio for their current fiscal year is 27.33, and their Forward P/E ratio for the next fiscal year is 18.44. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.79. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.96 while its Price-to-Book (P/B) ratio in mrq is 2.89. Its current Enterprise Value per Revenue stands at 5.223 whereas that against EBITDA is 10.679.
Stock Price History:
The Beta on a monthly basis for QGEN is 0.67, which has changed by 0.04991007 over the last 52 weeks, in comparison to a change of 0.1716845 over the same period for the S&P500. Over the past 52 weeks, QGEN has reached a high of $51.88, while it has fallen to a 52-week low of $37.63. The 50-Day Moving Average of the stock is -4.06%, while the 200-Day Moving Average is calculated to be 5.65%.
Shares Statistics:
QGEN traded an average of 1.47M shares per day over the past three months and 1705680 shares per day over the past ten days. A total of 216.83M shares are outstanding, with a floating share count of 214.96M. Insiders hold about 0.74% of the company’s shares, while institutions hold 77.24% stake in the company. Shares short for QGEN as of 1755216000 were 6126406 with a Short Ratio of 4.16, compared to 1752537600 on 6298552. Therefore, it implies a Short% of Shares Outstanding of 6126406 and a Short% of Float of 4.19.
Dividends & Splits
With its trailing 12-month dividend rate of 0.25, QGEN has a forward annual dividend rate of 0.25. Against a Trailing Annual Dividend Yield of 0.0053282185The current Payout Ratio is 0.00% for QGEN, which recently paid a dividend on 2025-07-02 with an ex-dividend date of 2025-07-02. Stock splits for the company last occurred on 2017-01-25 when the company split stock in a 962:1000 ratio.
